![Michael Bauer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Bauer
Direttore/Membro del Consiglio presso DECHRA PHARMACEUTICALS
Profilo
Michael Bauer is currently a Director at Dechra Pharmaceuticals Ltd., SPT Life Sciences Group, Seaport Topco Ltd., Viturin AG, Galderma Group AG, and EQT Partners AG.
He previously worked as a Director at Kuoni Reisen Holding AG and as the Chief Investment Officer at Capvis AG.
Mr. Bauer received his undergraduate degree from the University of St. Gallen in 2002 and his MBA from The University of Chicago Booth School of Business in 2010.
Posizioni attive di Michael Bauer
Società | Posizione | Inizio |
---|---|---|
DECHRA PHARMACEUTICALS | Direttore/Membro del Consiglio | - |
EQT Partners AG | Investitore di Private Equity | 01/08/2009 |
SPT Life Sciences Group
![]() SPT Life Sciences Group Medical SpecialtiesHealth Technology SPT Labtech Ltd. develops and manufactures automated laboratory equipment for both the academic and industrial sectors of pharmaceutical and biotechnology research. The firm provides liquid handling, sample management, and phenotypic and biologics screening. The company was founded by Jaspal Sanghera in 2001 and is headquartered in Royston, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Bauer
Società | Posizione | Fine |
---|---|---|
Capvis AG
![]() Capvis AG Investment ManagersFinance Capvis AG (Capvis), formerly known as Capvis Equity Partners AG, is an independent Swiss private equity firm headquartered in Baar, Switzerland, with additional offices in Frankfurt am Main (Germany), Shanghai (China), Jersey (Channel Islands), Luxembourg and Amsterdam (the Netherlands). The firm was established in 1990. | Direttore degli Investimenti | 09/10/2009 |
KUONI REISEN HOLDING AG | Direttore/Membro del Consiglio | - |
Formazione di Michael Bauer
University of St. Gallen | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Capvis AG
![]() Capvis AG Investment ManagersFinance Capvis AG (Capvis), formerly known as Capvis Equity Partners AG, is an independent Swiss private equity firm headquartered in Baar, Switzerland, with additional offices in Frankfurt am Main (Germany), Shanghai (China), Jersey (Channel Islands), Luxembourg and Amsterdam (the Netherlands). The firm was established in 1990. | Finance |
EQT Partners AG | Finance |
Kuoni Reisen Holding AG
![]() Kuoni Reisen Holding AG Other Consumer ServicesConsumer Services Kuoni Reisen Holding AG provides global travel-related services. It operates through the following segments: Group Travel, Fully Independent Traveller (FIT), Outbound Nordic, Outbound Europe/Asia, Destination Management Specialists and VFS Global. The company was founded by Alfred Kuoni in 1906 and is headquartered in Zurich, Switzerland. | Consumer Services |
SPT Life Sciences Group
![]() SPT Life Sciences Group Medical SpecialtiesHealth Technology SPT Labtech Ltd. develops and manufactures automated laboratory equipment for both the academic and industrial sectors of pharmaceutical and biotechnology research. The firm provides liquid handling, sample management, and phenotypic and biologics screening. The company was founded by Jaspal Sanghera in 2001 and is headquartered in Royston, the United Kingdom. | Health Technology |
Dechra Pharmaceuticals Plc
![]() Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Michael Bauer